ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/008/SRR3340638/SRR3340638.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/009/SRR3340639/SRR3340639.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/000/SRR3340640/SRR3340640.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/002/SRR3340642/SRR3340642.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/007/SRR3340637/SRR3340637.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/005/SRR3340645/SRR3340645.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/001/SRR3340641/SRR3340641.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/004/SRR3340644/SRR3340644.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/003/SRR3340643/SRR3340643.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR334/006/SRR3340636/SRR3340636.fastq.gzprimaryOK200GenomicsUniv Texas M.D. Anderson Cancer Centerhttps://www.ebi.ac.uk/ena/browser/view/PRJNA317532Homo sapiensxref:PubMed:27132940We report that the H2B deubiquitinating enzymes USP22, USP27x and USP51 have both unique and overlapping target loci. Overall design: Comparing H2Bb1 (K120) distribution profiles of MCF7 cells stably expressing shRNA targeting ATXN7L3, USP22, USP27X or USP51 and cells expressing non-targeting shRNA.ENADeubiquitinating, Proliferating, HITS-CLIP, High Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, HISTONE H2B, ChIP-Chip, Malignant Neoplasm, Activity, Chromatin Immuno-precipitation, Neoplasms, RGD1311493, postnatal development, Cross Linking and Immunoprecipitation Followed by Deep Sequencing, 1810057B09Rik, Benign Neoplasm, ChIP Sequencing, Deubiquitinase, CLIP-Seq, DC6, growth and development, Deubiquitinating Enzyme, H2BQ, Assay for Transposase-Accessible Chromatin Using Sequencing, H2B, Tumor, Malignant, ChIP-PET, 6720481I12, ChIP-Exo, Enzymes, development, E030022H21Rik, Benign, H2BGL105, Chromatin Immunoprecipitation Sequencing-Chip, Neoplasm, High-Throughput Sequencing of RNA Isolated by Crosslinking Immunoprecipitation, H2b, e(y)2, Chromatin Immunoprecipitation Sequencing Chip, Chromatin Immuno precipitation Sequencing, Malignancy, growth pattern, histone B2, ChIP, Deubiquitinases, non-developmental growth, Chromatin Immunoprecipitation Paired End Tag, proliferating, Chromatin Immuno Precipitation Paired End Tag, MRN17_11, postnatal growth, Cross-Linking and Immunoprecipitation Followed by Deep Sequencing, Benign Neoplasms, Chromatin Immunoprecipitation, H2B.1, Chromatin Immuno-precipitation Sequencing, Cancers, ChIP Exonuclease, ChIP-Seq, Sequencing, Assay for Transposase Accessible Chromatin Using Sequencing, Ey2, Malignant Neoplasms, MRN17.11, Chromatin Immunoprecipitation Paired-End Tag, Neoplasias, Enzyme, Proliferation, ChIA-PET., H2BFQ, Chromatin Immuno-Precipitation Paired-End Tag, ATAC-Seq, Chromatin Immunoprecipitation Sequencing-Chips, Malignancies, other neoplasm, GL105, growth, ChIP-Exonuclease, General activity, Neoplasia, HISTONE 2B, Cancer, TumorsHuman, Modern., human being, Man (Taxonomy), Homo sapiens, man, Man, human, Modern ManfalseHomo sapiensATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [ChIP-Seq]2025-09-242016-04-08PRJNA317532GSE79966960627132940